Products

  • Products
  • Service
  • Solutions
Consultation Center

Congratulations! Mabpharm’s CMAB807 Puboli® (Denosumab Injection) Granted Marketing Approval

Congratulations to Mabpharm on Puboli® Approval — New Breakthrough for Domestic mAbs

2026-06-18

Huzhou Shenke’s MAT Detection Successfully Supports the Approval of European CEP Registration for Polymyxin B Sulfate API

Huzhou Shenke (HZSKBIO®) assisted its client in obtaining the EU CEP certificate and provided registration support for active pharmaceutical ingredients (APIs) with its independently developed MAT method kit.

2026-05-26

HZSKBIOⓇ Debuts at CBioPC2026, Empowering High-quality Development of Biological Products Through Quality Control Innovation

HZSKBIO® debuted at CBioPC 2026 with its three core platforms: HCP Detection, Pyrogen Detection and Rapid Microbial Detection.

2026-05-22

HZSKBIOⓇ Assists GeneSail Biotech in GO321 Oncolytic Vaccinia Virus Project Securing IND Approval

Facilitate innovative drugs in obtaining clinical approvals and safeguard drug safety.

2026-05-12

Huzhou Shenke Shines at BPI 2026 The 11th New Molecule Antibody Drug R&D Forum

HZSKBIO® showcased its core products and services on site, and also delivered a special report entitled <span style="font-style: normal; font-variant: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-stretch: normal; font-family: ui-sans-serif, system-ui, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol", "Noto Color Emoji"; line-height: 24px; flex: 0 1 auto; flex-direction: row; justify-content:

2026-01-30

Filling the Market Gap in Postoperative Precise Assessment of Differentiated Thyroid Carcinoma in China! HZSKBIO® Supports Zelgen Biopharma in the Approval of Zesuning®

Guard Drug Safety, Facilitate Product Market Approval

2026-01-12

6records in total